http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1797611-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
filingDate 1991-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9b5a47c0c9d22a8dca3bac53d8dcad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb5e279cdb30b3f1ee5b6e8c8faa150
publicationDate 1993-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-1797611-C
titleOfInvention Method for separation cis-3-amino-4-[2-2-phuryl-et-1-yl]-1-methyxycarbonylmethyl-azetidine-2-on into its enantiomers
abstract Usage: in medicine for the synthesis of a medicament. SUMMARY OF THE INVENTION: Separation of the cis-3-amino-4- 2- (2-furyl) et-1-and 3-1-methoxycarbonylmethyl-azetidine-2-one racemate into cis-a, a-and cis -D / -enantiomers by contacting in the medium a polar organic solvent (heptane and / or isopropanol) with 0.5 molar equivalents of (-) hydrate - 2,3-4,6-di-b-isoprr - Pilidene-2-keto-and-gulonic acid, followed by separation of the precipitate co. whether the a, a isomer and the isolation of the salt of the /, / isomer from the solution. The degree of separation of isomers to 99.8%. 3 s, p. f-ly, 1 tab., / gh n "" o
priorityDate 1990-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449148440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457637794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410440661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID99291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415836523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14809448

Total number of triples: 42.